Skip to main content

McWherter Charles's Form 4 filing

CymaBay Therapeutics, Inc. (CBAY) · filed Dec 18, 2023

Accession no.
0001062993-23-022793
Filed
Dec 18, 2023
Trade date
Dec 18, 2023
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market sales total $243.5K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
McWherter CharlesCIK 0001588862Officer (President of R&D)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 18, 2023Common StockMOption exerciseAcquired+4,828$5.00+$24,14019,828Direct
Dec 18, 2023Common StockSSaleDisposed−4,828$21.49−$103,753.7215,000Direct
Dec 18, 2023Common StockMOption exerciseAcquired+6,504$5.00+$32,52021,504Direct
Dec 18, 2023Common StockSSaleDisposed−6,504$21.48−$139,705.9215,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 18, 2023Common StockMOption exerciseDisposed−704$0.00$00Direct
Dec 18, 2023Common StockMOption exerciseDisposed−234$0.00$00Direct
Dec 18, 2023Common StockMOption exerciseDisposed−3,890$0.00$00Direct
Dec 18, 2023Common StockMOption exerciseDisposed−6,504$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)